NO952904L - Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboksamide - Google Patents

Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboksamide

Info

Publication number
NO952904L
NO952904L NO952904A NO952904A NO952904L NO 952904 L NO952904 L NO 952904L NO 952904 A NO952904 A NO 952904A NO 952904 A NO952904 A NO 952904A NO 952904 L NO952904 L NO 952904L
Authority
NO
Norway
Prior art keywords
tenoyl
oxindole
fluoro
chloro
carboxamide
Prior art date
Application number
NO952904A
Other languages
English (en)
Norwegian (no)
Other versions
NO952904D0 (no
Inventor
Kelvin Cooper
Thomas Charles Crawford
Bruce H Littman
Christopher J Pazoles
Sally G Ruggeri
Keith D Wilner
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/007,217 external-priority patent/US5298522A/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO952904L publication Critical patent/NO952904L/no
Publication of NO952904D0 publication Critical patent/NO952904D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO952904A 1993-01-22 1995-07-21 Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboksamide NO952904D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/007,217 US5298522A (en) 1993-01-22 1993-01-22 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
US13827793A 1993-10-18 1993-10-18
PCT/US1994/000096 WO1994016694A1 (en) 1993-01-22 1994-01-06 Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (2)

Publication Number Publication Date
NO952904L true NO952904L (no) 1995-07-21
NO952904D0 NO952904D0 (no) 1995-07-21

Family

ID=26676677

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952904A NO952904D0 (no) 1993-01-22 1995-07-21 Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboksamide

Country Status (27)

Country Link
EP (1) EP0680321B1 (sh)
JP (1) JP2711939B2 (sh)
CN (1) CN1116822A (sh)
AP (1) AP468A (sh)
AT (1) ATE171373T1 (sh)
AU (1) AU671533B2 (sh)
BG (1) BG61966B1 (sh)
BR (1) BR9405661A (sh)
CA (1) CA2153050C (sh)
CZ (1) CZ182895A3 (sh)
DE (1) DE69413518T2 (sh)
DK (1) DK0680321T3 (sh)
DZ (1) DZ1748A1 (sh)
ES (1) ES2122236T3 (sh)
FI (1) FI940309A (sh)
HU (1) HUT69687A (sh)
IL (1) IL108326A0 (sh)
LV (1) LV10920B (sh)
MA (1) MA23095A1 (sh)
NO (1) NO952904D0 (sh)
NZ (1) NZ261449A (sh)
OA (1) OA10173A (sh)
PL (1) PL309957A1 (sh)
SK (1) SK91395A3 (sh)
UY (1) UY23723A1 (sh)
WO (1) WO1994016694A1 (sh)
YU (1) YU48719B (sh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE10106852A1 (de) * 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
DE4111306C2 (de) * 1991-04-08 1994-06-01 Mack Chem Pharm Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio

Also Published As

Publication number Publication date
LV10920A (lv) 1995-12-20
EP0680321A1 (en) 1995-11-08
NZ261449A (en) 1996-08-27
OA10173A (en) 1996-12-18
AU6019894A (en) 1994-08-15
LV10920B (en) 1996-04-20
AP9400609A0 (en) 1994-01-31
AU671533B2 (en) 1996-08-29
CN1116822A (zh) 1996-02-14
JPH08501109A (ja) 1996-02-06
HU9400176D0 (en) 1994-05-30
AP468A (en) 1996-03-05
CA2153050C (en) 1998-12-29
NO952904D0 (no) 1995-07-21
ES2122236T3 (es) 1998-12-16
BG61966B1 (bg) 1998-11-30
JP2711939B2 (ja) 1998-02-10
DE69413518T2 (de) 1999-02-11
BG99767A (bg) 1996-02-28
IL108326A0 (en) 1994-04-12
YU2394A (sh) 1996-10-18
HUT69687A (en) 1995-09-28
YU48719B (sh) 1999-07-28
ATE171373T1 (de) 1998-10-15
MA23095A1 (fr) 1994-10-01
PL309957A1 (en) 1995-11-13
DZ1748A1 (fr) 2002-02-17
DK0680321T3 (da) 1999-06-14
WO1994016694A1 (en) 1994-08-04
CZ182895A3 (en) 1996-01-17
EP0680321B1 (en) 1998-09-23
SK91395A3 (en) 1996-12-04
CA2153050A1 (en) 1994-08-04
BR9405661A (pt) 1995-11-21
UY23723A1 (es) 1994-06-28
FI940309A (fi) 1994-07-23
FI940309A0 (fi) 1994-01-21
DE69413518D1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
NO970532D0 (no) System og metode for blodbehandling
IS3805A (is) Amínósýruafleiður og aðferð við framleiðslu þeirra
IS1645B (is) Hliðstæð aðferð við að framleiða salt af lýsini og N,N'-tvíasetýlsystíni
NO990279D0 (no) Isobutylgaba og dets derivater for behandling av smerte
NO954690D0 (no) Intelligent akkompagnementsapparat og fremgangsmåte
DE69618650T2 (de) Chirugisches instrument zum behandeln der weiblichen harninkontinenz
NO970535D0 (no) Behandlingssystem for avgitt blod og metode for å danne regulerte virvelströmforhold
MY110402A (en) 6-chloro-5-fluoro-3-(2-thenoyl) -2-oxindole-1- carboxamide as an analgesic and anti-inflammatory agent
DE69614375D1 (de) Dermatologische zubereitung zur behandlung von aktinischen keratosen
AU5960394A (en) Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases
NO931445L (no) Overflatebehandling og fremgangsmaate for tilvirkning av disse
NO177731C (no) F¶rprodukt og fremgangsmÕte for fremstilling av samme
IS1877B (is) Aðferð til framleiðslu á N-metýl-3-(1-metýl-4-píperidinýl)-1H-indól-5- etansúlfonamíð og lífeðlisfræðilega viðunandi söltum þess og lausnum þeirra
NO952904L (no) Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboksamide
FI925944A (fi) Arylalkylestrar av 4,5-dihydroxi-9,10-dihydro-9,10-dioxo-2-antracenkarboxylsyra med terapeutisk effekt
NO973193D0 (no) Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer
IS3984A (is) Aðferð við framleiðslu á lyfjablöndu sem ætluð ertil staðbundinnar meðferðar við liðagigt og notkun á henni
NO924519L (no) Fremgangsmaate og anordning for magnetisk avfoeling
UA10998C2 (uk) Спосіб поліфакторhої лікувальhої дії та ковдра для поліфакторhої лікувальhої дії
SG54127A1 (en) Method for producing optically active 3-substituted-2-norbornanones and their immediates
UA24712A (uk) Спосіб раhhьої профілактики захворюваhь вhутрішhіх оргаhів у робітhиків коксохімічhого виробhицтва
IL107493A0 (en) A device and method for the treatment of rheumatic diseases
FI940252A0 (fi) Menetelmä ja laite ihokudoksen pelkistämiseksi
MX9706825A (es) El uso farmacologico de ciertos derivados de cistina.
NO177610C (no) Fremgangsmåte og anordning for å generere lyd i et rom for mennesker